Price $2.62 |
Market Cap
12.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.4
|
P/S
2.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-16.3K
|
FCF
-3.3
|
|
Op. Margin
-
|
Net Margin
-389.40%
|
ROE
-57.00%
|
ROI
-65.60%
|
|
ROA
-39.60%
|
EPS Growth
-147.30%
|
Current Ratio
7.9
|
Debt/Equity
0.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Item 9 Labs Corp (INLB) | $0.01 | - | - | 5.4M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.10 | - | - | 4.7M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.14 | - | - | 12.3M | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.19 | - | - | 126.6M | Strong Buy |
| PAVmed Inc (PAVM) | $0.34 | - | - | 42.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
